logo
COVID claims 3 lives in 2 days, toll rises to 15

COVID claims 3 lives in 2 days, toll rises to 15

NEW DELHI: The national capital reported three more Covid-19 related fatalities in the past 48 hours, pushing the city's death toll to 15, officials said on Thursday. All the deceased were senior citizens and had multiple pre-existing health conditions, according to the health dept.
"Two of the deaths were reported on Thursday, both women, aged 67 and 74. The 67-year-old had a history of hypertension and chronic kidney disease," said officials.
She was also diagnosed with COVID pneumonia and sepsis, and succumbed to refractory septic shock, they added.
The other deceased, the 74-year-old woman was suffering from coronary artery disease, rheumatoid arthritis, lower respiratory tract infection and septic shock. She eventually died due to multiple organ dysfunction syndrome, officials informed.
An earlier death was reported on Wednesday, involving a 65-year-old man who had carcinoma of the oral cavity, acute kidney injury and acute respiratory distress syndrome. According to officials, all three were undergoing treatment when they passed away.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Southern Railway launches telemedicine link to bring specialist care to remote railway units
Southern Railway launches telemedicine link to bring specialist care to remote railway units

Time of India

time24 minutes ago

  • Time of India

Southern Railway launches telemedicine link to bring specialist care to remote railway units

SR general manager R N Singh inaugurated the telemedicine facility. CHENNAI: Southern Railway has launched an integrated telemedicine facility in railway hospitals and health units, allowing patients in remote areas to access specialist and super-specialist care without travelling long distances. Inaugurated by general manager R N Singh at the Southern Railway Headquarters Hospital in Perambur on Friday, the system links divisional hospitals and health units to the headquarters hospital here. The facility was developed under the Government of India's e-Sanjeevani scheme. Using real-time video consultations and live streaming of diagnostic reports such as ECGs and X-rays, medical officers at remote locations can now consult directly with specialists at Perambur, streamlining treatment decisions. Officials said the facility proved crucial during the Covid-19 pandemic and is now the first of its kind in Indian Railways. During the launch, Singh witnessed a live consultation from the Divisional Railway Hospital in Madurai and urged officials to ensure high-speed internet across all health units. He reviewed new digital queue systems and signage boards at the Perambur OPD block.

Airborne fungal spores may help predict Covid, flu surge: Study
Airborne fungal spores may help predict Covid, flu surge: Study

Hans India

time2 hours ago

  • Hans India

Airborne fungal spores may help predict Covid, flu surge: Study

New Delhi: Monitoring fungal spores in the outdoor air can predict surges in flu and Covid-19 infections, according to a study. Researchers from Lynn University in Florida, US, discovered that airborne concentrations of fungal spores -- but not pollen -- were strongly linked to increases in flu and Covid-19 cases. When airborne concentrations of fungal spores rose, the scientists often saw a jump in infections within a few days. The study models were able to predict flu and Covid-19 surges with high accuracy, particularly in the fall season. However, pollen didn't show the same connection or prediction. 'The findings from our study suggest that monitoring airborne fungal spore levels could help predict short-term outbreaks (spikes) of flu and Covid-19, giving public health systems an early warning signal,' said Felix E. Rivera-Mariani, Associate Professor of Biochemistry at Lynn. 'Our findings also highlight the potential role of environmental factors -- not just person-to-person spread -- in contributing to the incidence of respiratory viral infections. That could open new doors for targeted public health alerts, especially in areas with high outdoor airborne fungi," Rivera-Mariani added. In the study, the team examined daily data from 2022 to 2024, in two major health regions in Puerto Rico—San Juan and Caguas. The data included the daily incidence of people diagnosed with Covid-19 and flu, and the concentrations of airborne fungal spores and pollen recorded on the same days. The scientists then implemented statistical and machine learning models to see if high levels of these environmental exposures could predict spikes in flu and Covid-19 cases within the same week or the following week (called lag-effect). 'The findings may help inform environmental risk alerts, particularly for vulnerable populations like the elderly or those with asthma and allergic rhinitis,' Rivera-Mariani said. The study was presented at ASM Microbe 2025 in Los Angeles, the annual meeting of the American Society for Microbiology.

What you need to know about the ‘razor blade' Covid variant
What you need to know about the ‘razor blade' Covid variant

The Hindu

time3 hours ago

  • The Hindu

What you need to know about the ‘razor blade' Covid variant

Covid-19, it seems, can never stay out of the news for very long. One variant of the virus has been making headlines recently for being behind a spike in cases, particularly in China and the United States, and for causing 'razor blade' throats, or a severely painful sore throat. What do you need to know about this? Read on, to find out. The 'razor blade' throat, reports indicate, is being caused by the NB.1.8.1 variant of the virus, an Omicron-descendent variant dubbed as 'Nimbus' and currently accounting for a large number of cases worldwide. On May 23, 2025, the World Health Organization classified this variant as a 'SARS-CoV-2 variant under monitoring (VUM) with increasing proportions globally, while LP.8.1 is starting to decline.' A technical document by the WHO states: 'Considering the available evidence, the additional public health risk posed by NB.1.8.1 is evaluated as low at the global level. Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease. Despite a concurrent increase in cases and hospitalizations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation.' Symptoms remain similar to those caused by other Covid-19 strains and include fever, a sore throat, cough, runny nose and tiredness. Media reports indicate some patients complaining of a sharp, stabbing pain while swallowing, often at the back of the throat, akin to 'swallowing a razor blade'. However, it is unclear if this is a distinctive symptom of this variant The WHO, in its technical document, had said spike mutations in this variant could increase its transmissibility. In India, according to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), one case of NB.1.8.1 was identified in April in Tamil Nadu and four cases of LF.7 were detected in Gujarat in May. As of May, the most common variant remained JN.1, comprising 53 % of samples tested, followed by BA.2 (26 %) and other Omicron sublineages (20 %). In June, a media report stated about 163 cases of the COVID-19 variant XFG, had been detected, according to INSACOG data. Earlier this week, Naveen Kumar, Director, National Institute of Virology (NIV), Pune, said surveillance and genome sequencing have been scaled up. He said genomic analysis had revealed the surge was due to the JN.1.16 sub-lineage of the Omicron variant, and that since May 2025, it had been replaced by the XFG (LF.7 and LP.81.2) recombinant variant. Doctors in India have reiterated that Covid-19 is now co-circulating with other seasonal infections and that they do not expect any major waves of the kind seen in 2021 and 2021. Spikes and dips however, may continue. Personal protection and hygiene measures such as hand washing, avoiding crowded places when possible or masking up, and protecting vulnerable segments of the population must continue, they have said. As of Friday, June 20, 2025, India's tally of active Covid-19 cases dipped to 5,608 from the 7,000 plus mark last week, and four new deaths were reported, taking the total toll this year to 120.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store